Article
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
Breast cancer research : BCR - 1 Jan 2010
Walker Logan C, Fredericksen Zachary S, Wang Xianshu, Tarrell Robert, Pankratz Vernon S, Lindor Noralane M, Beesley Jonathan, Healey Sue, Chen Xiaoqing, Stoppa-Lyonnet Dominique, Tirapo Carole, Giraud Sophie, Mazoyer Sylvie, Muller Danièle, Fricker Jean-Pierre, Delnatte Capucine, Schmutzler Rita K, Wappenschmidt Barbara, Engel Christoph, Schönbuchner Ines, Deissler Helmut, Meindl Alfons, Hogervorst Frans B, Verheus Martijn, Hooning Maartje J, van den Ouweland Ans Mw, Nelen Marcel R, Ausems Margreet Gem, Aalfs Cora M, van Asperen Christi J, Devilee Peter, Gerrits Monique M, Waisfisz Quinten, Szabo Csilla I, Easton Douglas F, Peock Susan, Cook Margaret, Oliver Clare T, Frost Debra, Harrington Patricia, Evans D Gareth, Lalloo Fiona, Eeles Ros, Izatt Louise, Chu Carol, Davidson Rosemarie, Eccles Diana, Ong Kai-Ren, Cook Jackie, Rebbeck Tim, Nathanson Katherine L, Domchek Susan M, Singer Christian F, Gschwantler-Kaulich Daphne, Dressler Anne-Catharina, Pfeiler Georg, Godwin Andrew K, Heikkinen Tuomas, Nevanlinna Heli, Agnarsson Bjarni A, Caligo Maria Adelaide, Olsson Håkan, Kristoffersson Ulf, Liljegren Annelie, Arver Brita, Karlsson Per, Melin Beatrice, Sinilnikova Olga M, McGuffog Lesley, Antoniou Antonis C, Chenevix-Trench Georgia, Spurdle Amanda B, Couch Fergus J
Abstract excerpt
INTRODUCTION: Current attempts to identify genetic modifiers of BRCA1 and BRCA2 associated risk have focused on a candidate gene approach, based on knowledge of gene functions, or the development of large genome-wide association studies. In this study, we evaluated 24 SNPs tagged to 14 candidate...
Read the complete abstract on PubMed